| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 977.9 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This work presents MMCTO, a multimodal framework predicting clinical trial outcomes by
integrating molecular, disease, and eligibility data. Based on the LIFTED architecture, it
employs natural language transformation and a Mixture-of-Experts mechanism to unify
heterogeneous inputs. It demonstrates superior predictive performance across trial phases on
HINT and CTOD datasets. Ablation studies confirm the importance of LLM-generated features
and conditioned gating. A RAG pipeline contextualizes results, while SHAP explanations
provide transparency. The approach optimizes resources and streamlines processes, potentially
avoiding costly failures and accelerating drug development timelines.
Descrição
Palavras-chave
Clinical trial outcomes Large Language Models Mixture-of-Experts LIFTED Retrieval-Augmented-Generation SHAP
